Breadcrumb
Researchers - Title

Research - Our Team

PeopleCategories
People
Marcela Villota

Marcela Villota

Research Assistant

Marcela Villota-Rivas, MGH, is a public health systems research assistant, with a background in dietetics, for work focusing on non-communicable (metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH)) and communicable (viral hepatitis) liver disease. 

Lines of research

  • MASLD/MASH
  • Health systems
  • Viral hepatitis
  • Integrated care
  • Stigma and discrimination

Main publications

  • Díaz LA, Villota-Rivas M, et al. The burden of liver disease in Latin America. Ann Hepatol 2023 doi: 10.1016/j.aohep.2023.101175
  • Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Anstee QM, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Gastaldelli A, Hagström H, Huang TT-K, Wajcman DI, Kautz A, Kopka CJ, Krag A, Miller V, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Terrault NA, Tsochatzis EA, Valenti L, Villota-Rivas M, et al. A global action agenda for turning the tide on fatty liver disease. Hepatology 2023 doi: 10.1097/HEP.0000000000000545
  • Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023 doi: 10.1097/HEP.0000000000000520
  • Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Hagström H, Huang TT-K, Wajcman DI, Kautz A, Kopka CJ, Krag A, Miller V, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Tsochatzis EA, Valenti L, Villota-Rivas M, et al. A global research priority agenda to advance public health responses to fatty liver disease. J Hepatol 2023 doi: 10.1016/j.jhep.2023.04.035
  • Lazarus JV, Villota-Rivas M, et al. Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain. Commun Med (Lond) 2023 doi: 10.1038/s43856-023-00292-y
  • Lazarus JV, Villota-Rivas M, et al. Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease. Clin Liver Dis 2023 doi: 10.1016/j.cld.2023.01.021
Asset Publisher